http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-210355656-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0729b244445c470818ee3f4d96f79b1b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-07 |
| filingDate | 2019-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f98178958d6ab6b8f0caae0e5a8f8916 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1531916816afd7e7a7d3242d3a2bfcbc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_513e2f0962b0dfe4e9e896d33e8892a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fb2000a8870ae0501ae5c07053b39e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74a538d0638947fd6c04c0d062a4c7a3 |
| publicationDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-210355656-U |
| titleOfInvention | Enteric controlled release device for treating clostridium difficile infection |
| abstract | The utility model discloses an enteric controlled release device for treating clostridium difficile infection, which relates to the technical field of medicine and comprises a capsule body and medicines in the capsule body; the utility model discloses it is convenient to dose, and the cure rate is high, and wherein excrement fungus liquid gets rid of residue and the ultracentrifuge after long-pending fungus through the centrifugation and pours into the capsule originally internally, reducible a lot of adverse reactions, and add the paracresol that alcaligenes faecalis decomposed clostridium difficile and is produced, destroys its microenvironment that relies on to survive, and then eliminates this fungus from the etiology. Meanwhile, the ZINPLAVA capable of locally and slowly releasing the exotoxin B of clostridium difficile is also used for relieving the damage to intestinal cells caused by the ZINPLAVA; the capsule body and the capsule cap are in threaded sealing connection, so that the probability of medicine overflow in the capsule body is reduced, the strength of the capsule body and the capsule cap can be increased through the first support and the second support, the probability of deformation or damage of the capsule body and the capsule cap is reduced, and the probability of medicine overflow in the capsule body is further reduced. |
| priorityDate | 2019-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.